The 1935 Rockefeller Foundation annual report acknowledges funding Dr. Corner’s research:  “To the University of Rochester, for research on the physiology of reproduction under the direction of Dr. G. W. Corner during the threeyear period beginning July 1, 1935, and ending June 30, 1938, there has been appropriated the sum of $9,900. Dr. Corner’s activities are concentrated on a study of the oestrus cycle, using monkeys as the experimental animals. A colony of about thirty monkeys has been maintained, and experiments have furnished information on the normal histology of the reproductive cycle, the time of ovulation, the relation of ovulation to menstruation and other anatomically detectable correlations of the oestrus cycle. Work is continuing on two main lines: normal sex reproduction in the monkey, including the histology of ovary and uterus, and, secondly, the effects of the ovarian hormone.” [2012] Rockefeller Anti-Fertility Vaccines Exposed

The Foundation’s 1934 annual report states: “The Rockefeller Foundation has decided to concentrate its present effort in the natural sciences on the field of modern experimental biology, with special interest in such topics as endocrinology, nutrition, genetics, embryology, problems centering about the reproductive process, psychobiology, general and cellular physiology, biophysics, and biochemistry.”  “(…) research work is being conducted on the physiology of reproduction in the monkey. This work was begun at the Johns Hopkins University in 1921, and since 1923 has been continued at the University of Rochester. It involves observational and experimental studies of the reproductive cycle in certain species of the higher primates, in which this cycle closely resembles that of the human species. The effect of the various interrelated reproductive hormones is being studied.” [2012] Rockefeller Anti-Fertility Vaccines Exposed

In the annual report of the previous year (1933), the Foundation stresses the fact that work on the reproductive hormones of primates serves to experiment on man in the future: “(…) much work has been done in the formulation and solution of basic problems in the general biology and physiology of sex in organisms other than man. It was essential that this fundamental work on infra-man pave the way for that on man.” [2012] Rockefeller Anti-Fertility Vaccines Exposed

In its 1968 yearly report, the Rockefeller Foundation acknowledged funding the development of so-called “anti-fertility vaccines” and their implementation on a mass-scale. From page 51 onward we read:  “(…) several types of drugs are known to diminish male fertility, but those that have been tested have serious problems of toxicity. Very little work is in progress on immunological methods, such as vaccines, to reduce fertility, and much more research is required if a solution is to be found here.” [2012] Rockefeller Anti-Fertility Vaccines Exposed

A 2006, National Geographic article Toxin-Free Cottonseed Engineered; Could Feed Millions Study Says, quotes the director of the Laboratory for Crop Transformation (Texas A&M Universtity), Keerti Singh Rathore as saying: “A gossypol-free cottonseed would significantly contribute to human nutrition and health, particularly in developing countries, and help meet the requirements of the predicted 50 percent increase in the world population in the next 50 years.”  “Rathore’s study”, states the article, “represents the first substantiated case where gossypol was reduced via genetic engineering that targets the genes that make the toxin.”  I bring into recollection the statement made by the Rockefeller Foundation in its 1986 annual report, which reads:  “Before widespread use can be recommended, further investigation is needed to see if lowering the dosage can eliminate undesirable side-effects without reducing its effectiveness as a contraceptive.” [2012] Rockefeller Anti-Fertility Vaccines Exposed

The last mention of gossypol in the Foundation’s annals we find in the 1994 annual report, where funds were appropriated to the University of Innsbruck of Austria “for a study at the Institute of Physiology on the molecular action of gossypol at the cellular level.”  It seems that the funded scientists have indeed found a way of “lowering the dosage” of gossypol, circumventing the toxicity of the substance, so as to suppress or even eliminate these “undesirable side-effects”, which include: low blood potassium levels, fatigue, muscle weakness and even paralysis. If these effects could be eliminated without reducing the anti-fertility effects, the Foundation figured, it would be a highly effective and almost undetectable sterilant. [2012] Rockefeller Anti-Fertility Vaccines Exposed

[pdf] 1989 Rockefeller annual report, funds were allocated to several research institutions to see how this “dose reduction” could best be accomplished without interfering with the ant-fertility effects of gossypol.  (1988- $ 400,000, in addition to remaining funds from prior year appropriations) To support research on gossypol, its safety, reversibility, and efficacy as a contraceptive for use by men (…).”  Mention is made on money allocated to the University of Texas, “for a study of gossypol’s effects on DNA replication (…).” [2012] Rockefeller Anti-Fertility Vaccines Exposed

In the RF’s 1988 annual report, gossypol as a contraceptive was also elaborated upon (page 22):   “Gossypol, a natural substance found in the cotton plant, continues to show promise as an oral contraceptive for men. Because it suppresses sperm production without affecting sex hormone levels, it is unique among the experimental approaches to fertility control in men. Foundation-funded scientists worldwide have assembled an aray of information about how gossypol works, and studies continue on a wide variety of its clinical applications. Dose reduction is being investigated to reduce health risks associated with the use of gossypol.” [2012] Rockefeller Anti-Fertility Vaccines Exposed

1986 Rockefeller Foundation annual report, the organization admits funding research into the use of fertility-reducing compounds in relation to food for “widespread use”:  
    “Male contraceptive studies are focused on gossypol, a natural substance extracted from the cotton plant, and identified by Chinese researchers as having an anti-fertility effect on men. Before widespread use can be recommended, further investigation is needed to see if lowering the dosage can eliminate undesirable side-effects without reducing its effectiveness as a contraceptive. The Foundation supported research on gossypol’s safety, reversibility and efficacy in seven different 1986 grants.” [2012] Rockefeller Anti-Fertility Vaccines Exposed

[pdf] 1985 Rockefeller Foundation’s annual report underlined its ongoing dedication towards finding good use for the anti-fertility substance “gossypol”, or C30H30O8 – as the description reads. Indeed, gossypol, a toxic polyphenol derived from the cotton plant, was identified early on in the Foundation’s research as an effective sterilant. The question was, how to implement or integrate the toxic substance into crops. “Another long-term interest of the Foundation has been gossypol, a compound that has been shown to have an antifertility effect in men, By the end of 1985, the Foundation had made grants totaling approximately $1.6 million in an effort to support and stimulate scientific investigations on the safety and efficacy of gossypol.” [2012] Rockefeller Anti-Fertility Vaccines Exposed

One of the Task Force members, P.D. Griffin, outlined the purpose and trajectory of these Fertility Regulating Vaccines. Griffin:  “The Task Force has continued to coordinate its research activities with other vaccine development programmes within WHO and with other international and national programmes engaged in the development of fertility regulating vaccines.”  Griffin also admitted to the fact that one of the purposes of the vaccines is the implementation in developing countries. Griffin: “If vaccines could be developed which could safely and effectively inhibit fertility, without producing unacceptable side effects, they would be an attractive addition to the present armamentarium of fertility regulating methods and would be likely to have a significant impact on family planning programmes.” Also, one of the advantages of the FRVs over “currently available methods of fertility regulation” the Task Force states, is the following (179): “low manufacturing cost and ease of delivery within existing health services.” [2012] Rockefeller Anti-Fertility Vaccines Exposed

In August of 1992, a series of meetings was held in Geneva, Switzerland, regarding “fertility regulating vaccines”. According to the document Fertility Regulating Vaccines (classified by the WHO with a limited distribution) present at those meetings were scientists and clinicians from all over the globe, including then biomedical researcher of the American Agency for International development, and current research-chief of USAID, Mr. Jeff Spieler.   In 1986 Mr. Spieler declared: 
    “A new approach to fertility regulation is the development of vaccines directed against human substances required for reproduction. Potential candidates for immunological interference include reproductive hormones, ovum and sperm antigens, and antigens derived from embryonic or fetal tissue.(…). An antifertility vaccine must be capable of safely and effectively inhibiting a human substance, which would need somehow to be rendered antigenic. A fertility-regulating vaccine, moreover, would have to produce and sustain effective immunity in at least 95% of the vaccinated population, a level of protection rarely achieved even with the most successful viral and bacterial vaccines. But while these challenges looked insuperable just a few years ago, recent advances in biotechnology- particularly in the fields of molecular biology, genetic engineering and monoclonal antibody production- are bringing antifertility vaccines into the realm of the feasible.”
    “Vaccines interfering with sperm function and fertilization could be available for human testing by the early 1990s”, Spieler wrote.
    In order for widespread use of these vaccines, Spieler writes, the vaccine must conquer “variations in individual responses to immunization with fertility-regulating vaccines”.
    “Research”, he goes on to say,” is also needed in the field of “basic vaccinology”, to find the best carrier proteins, adjuvants, vehicles and delivery systems.”
In the 1992 document, the problem of “variations in individual responses” is also discussed:
    “Because of the genetic diversity of human populations”, states the document, “immune responses to vaccines often show marked differences from one individual to another in terms of magnitude and duration. These differences may be partly or even completely overcome with appropriately engineered FRVs (Fertility Regulating Vaccines) and by improvements in our understanding of what is required to develop and control the immune response elicited by different vaccines.” [2012] Rockefeller Anti-Fertility Vaccines Exposed

The 1985 Rockefeller Foundation’s annual report underlined its ongoing dedication towards finding good use for the anti-fertility substance “gossypol”, or C30H30O8 – as the description reads. Indeed, gossypol, a toxic polyphenol derived from the cotton plant, was identified early on in the Foundation’s research as an effective sterilant. The question was, how to implement or integrate the toxic substance into crops. “Another long-term interest of the Foundation has been gossypol, a compound that has been shown to have an antifertility effect in men, By the end of 1985, the Foundation had made grants totaling approximately $1.6 million in an effort to support and stimulate scientific investigations on the safety and efficacy of gossypol.” [2012] Rockefeller Anti-Fertility Vaccines Exposed

In the 1986 Rockefeller Foundation annual report, the organization admits funding research into the use of fertility-reducing compounds in relation to food for “widespread use”: “Male contraceptive studies are focused on gossypol, a natural substance extracted from the cotton plant, and identified by Chinese researchers as having an anti-fertility effect on men. Before widespread use can be recommended, further investigation is needed to see if lowering the dosage can eliminate undesirable side-effects without reducing its effectiveness as a contraceptive. The Foundation supported research on gossypol’s safety, reversibility and efficacy in seven different 1986 grants.” [2012] Rockefeller Anti-Fertility Vaccines Exposed

The following year, according to the annual report, funds were allocated to several research institutions to see how this “dose reduction” could best be accomplished without interfering with the ant-fertility effects of gossypol. (1988- $ 400,000, in addition to remaining funds from prior year appropriations) To support research on gossypol, its safety, reversibility, and efficacy as a contraceptive for use by men (…).”  Mention is made on money allocated to the University of Texas, “for a study of gossypol’s effects on DNA replication (…).” [2012] Rockefeller Anti-Fertility Vaccines Exposed

The 1935 Rockefeller Foundation annual report acknowledges funding Dr. Corner’s research: “To the University of Rochester, for research on the physiology of reproduction under the direction of Dr. G. W. Corner during the threeyear period beginning July 1, 1935, and ending June 30, 1938, there has been appropriated the sum of $9,900. Dr. Corner’s activities are concentrated on a study of the oestrus cycle, using monkeys as the experimental animals. A colony of about thirty monkeys has been maintained, and experiments have furnished information on the normal histology of the reproductive cycle, the time of ovulation, the relation of ovulation to menstruation and other anatomically detectable correlations of the oestrus cycle. Work is continuing on two main lines: normal sex reproduction in the monkey, including the histology of ovary and uterus, and, secondly, the effects of the ovarian hormone.” [2012] Rockefeller Anti-Fertility Vaccines Exposed

In the annual report of the previous year (1933), the Foundation stresses the fact that work on the reproductive hormones of primates serves to experiment on man in the future: “(…) much work has been done in the formulation and solution of basic problems in the general biology and physiology of sex in organisms other than man. It was essential that this fundamental work on infra-man pave the way for that on man.” [2012] Rockefeller Anti-Fertility Vaccines Exposed

By the mid-1930s, Mason of the Rockefeller Foundation thought that “the ultimate solution of the problem [of birth control] may well lie in the studies of endocrinology, particularly antihormones.” The Foundation’s 1934 annual report states:  “The Rockefeller Foundation has decided to concentrate its present effort in the natural sciences on the field of modern experimental biology, with special interest in such topics as endocrinology, nutrition, genetics, embryology, problems centering about the reproductive process, psychobiology, general and cellular physiology, biophysics, and biochemistry.”  “(…) research work is being conducted on the physiology of reproduction in the monkey. This work was begun at the Johns Hopkins University in 1921, and since 1923 has been continued at the University of Rochester. It involves observational and experimental studies of the reproductive cycle in certain species of the higher primates, in which this cycle closely resembles that of the human species. The effect of the various interrelated reproductive hormones is being studied.” [2012] Rockefeller Anti-Fertility Vaccines Exposed

The last mention of gossypol in the Foundation’s annals we find in the 1994 annual report, where funds were appropriated to the University of Innsbruck of Austria “for a study at the Institute of Physiology on the molecular action of gossypol at the cellular level.”  It seems that the funded scientists have indeed found a way of “lowering the dosage” of gossypol, circumventing the toxicity of the substance, so as to suppress or even eliminate these “undesirable side-effects”, which include: low blood potassium levels, fatigue, muscle weakness and even paralysis. If these effects could be eliminated without reducing the anti-fertility effects, the Foundation figured, it would be a highly effective and almost undetectable sterilant.  Although overtly, research into and development of gossypol as an anti-fertility compound was abandoned in the late 1990s, the cottonseed containing the substance was especially selected for mass distribution in the beginning of the current decade. Around 2006 a media-campaign was launched, saying the cottonseed could help defeat hunger and poverty. [2012] Rockefeller Anti-Fertility Vaccines Exposed

In the RF’s 1988 annual report, gossypol as a contraceptive was also elaborated upon (page 22): “Gossypol, a natural substance found in the cotton plant, continues to show promise as an oral contraceptive for men. Because it suppresses sperm production without affecting sex hormone levels, it is unique among the experimental approaches to fertility control in men. Foundation-funded scientists worldwide have assembled an aray of information about how gossypol works, and studies continue on a wide variety of its clinical applications. Dose reduction is being investigated to reduce health risks associated with the use of gossypol.” [2012] Rockefeller Anti-Fertility Vaccines Exposed

The Women’s Global Network for Reproductive Rights based in Amsterdam, the Netherlands, quoted “a leading contraceptive researcher as saying: “Immunological birth control methods will be an ‘antigenic weapon’ against the reproductive process, which left unchecked, threatens to swamp the world.” [2012] Rockefeller Anti-Fertility Vaccines Exposed

It wasn’t long before all the Foundation’s efforts began to have effect. In its annual report of 1988, The RF was happy to report the progress made by the Foundation’s Population Division in the field of anti-fertility vaccines:   “India’s National Institute of Immunology successfully completed in 1988 the first phase of trials with three versions of an anti-fertility vaccine for women. Sponsored by the government of India and supported by the Foundation, the trials established that with each of the tested vaccines, at least one year of protection against pregnancy could be expected, based on the levels of antibodies formed in response to the immunization schedule.” [2012] Rockefeller Anti-Fertility Vaccines Exposed

Betsy Hartman, Director of the Population and Development Program at Hampshire College, Massachusetts and “someone who believes strongly in women’s right to safe, voluntary birth control and abortion”, is no supporter of the anti-fertility vaccine, as brought into being by the Rockefeller Foundation. She explains in her essay Population control in the new world order: “Although one vaccine has been tested on only 180 women in India, it is being billed there as ‘safe, devoid of any side effects and completely reversible’. The scientific community knows very well that such assertions are false – for instance, many questions still remain about the vaccine’s long-term impact on the immune system and menstrual cycle. There is also evidence on film of women being denied information about the vaccine in clinical trials. Nevertheless, the vaccine is being prepared for large-scale use.” [2012] Rockefeller Anti-Fertility Vaccines Exposed

In its 1997 review of anti-fertility vaccines, Indian based International Centre for Genetic Engineering and Biotechnology didn’t forget to acknowledge its main benefactor: “The work on LHRH and HCG vaccines was supported by research grants of The Rockefeller Foundation, (…).” [2012] Rockefeller Anti-Fertility Vaccines Exposed